HealthEquity (HQY) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended January 2025, HealthEquity (HQY Quick QuoteHQY – Free Report) reported revenue of $311.82 million, up 18.8% over the same period last year. EPS came in at $0.69, compared to $0.63 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $305.1 million, representing a surprise of +2.20%. The company delivered an EPS surprise of -2.82%, with the consensus EPS estimate being $0.71.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company’s financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock’s price performance more accurately.

Here is how HealthEquity performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Total HSA Assets: $32.11 billion compared to the $31.65 billion average estimate based on three analysts.
• Total HSA investments: $14.68 billion compared to the $14.18 billion average estimate based on three analysts.
• CDBs Accounts: 7.14 million versus 6.87 million estimated by three analysts on average.
• Total Accounts: 17.03 million versus the three-analyst average estimate of 16.53 million.
• Total HSA cash: $17.44 billion versus the three-analyst average estimate of $17.48 billion.
• HSAs Accounts: 9.89 million versus 9.67 million estimated by three analysts on average.
• Revenue- Service: $124.21 million versus the four-analyst average estimate of $122.45 million. The reported number represents a year-over-year change of +4.8%.
• Revenue- Custodial: $144.13 million versus $140.18 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +36.7% change.
• Revenue- Interchange: $43.48 million versus $41.27 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +13.3% change.

View all Key Company Metrics for HealthEquity here>>>

Shares of HealthEquity have returned -10.6% over the past month versus the Zacks S&P 500 composite’s -7% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.